Medical technology company Sensodetect is ending an international collaboration by mutual agreement as part of the company’s strategy to focus on broader commercial opportunities and long-term scalable partnerships.The company states that the change is not expected to have any material impact on operations or the financial position. Work in the United Arab Emirates and regulatory activities in Saudi Arabia continue as planned.Sensodetect also states that the company continues to evaluate international opportunities within decision support and screening solutions for neuroscience and mental health.